Valuation + Options Snapshot

CVS

$95.42 · 52-week range $69.51 – $110.68 · as of 2026-09-10

Value

Fair

Volatility setup

Fair

What the numbers show

  • P/E 25.2× vs 5y median 16.6× — 52.0% above its own history.
  • FCF yield 9.6% — rich.
  • Dividend yield 2.79% — well covered by TTM FCF (3.5×).
  • YoY growth — revenue +7.4%, EPS +5.6%, FCF +146.0%.
  • Share count up 1.6% over 8 quarters — modest dilution.
  • ATM IV 30.6% vs trailing realized vol 31.2% — -0.6 vol points (roughly fair).
  • Liquid chain — ATM-band put OI 24,998.

Current P/E

25.2×

5y median P/E

16.6×

vs 5y median

+52.0%

FCF yield

9.63%

Dividend yield

2.79%

Coverage (FCF / div)

3.5×

Revenue YoY

+7.4%

EPS YoY

+5.6%

FCF YoY

+146.0%

Shares Δ (8 quarters)

+1.6%

ATM implied vol

30.6%

Realized vol (1y)

31.2%

IV − RV

-0.6 pts

ATM-band put OI

24,998

Range position

27% above low

Run this analysis on any ticker

Score any name on VOL’s two-axis framework, or calculate the annualized yield of a put-selling setup against live market data.

This page is not a recommendation. It shows structural numbers and classification only. Whether CVS is a name worth owning — at any price or strike — is the analyst work the paid Value Options Letter does every week.